These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 15339577
1. [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B]. Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Tang BZ, He J. Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):89-98, 102. PubMed ID: 15339577 [Abstract] [Full Text] [Related]
2. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B. Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Zhou RX, He J, Tang BZ. World J Gastroenterol; 2005 May 21; 11(19):2892-9. PubMed ID: 15902724 [Abstract] [Full Text] [Related]
3. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment]. Hu YY, Liu P, Liu C. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan 21; 26(1):18-22. PubMed ID: 16466166 [Abstract] [Full Text] [Related]
4. [Clinical study of yiqi huoxue recipe in the treatment of liver fibrosis of chronic viral hepatitis]. Cui LY, Zhang XX, Cui P, Li WC, Zhang YG, Wang RQ, Zhao SX, Ren WG, Kong LL, Han F, Yuan XW, Liu LD, Zhang Y, Zhang QS, Kong L, Nan YM. Zhonghua Gan Zang Bing Za Zhi; 2020 May 20; 28(5):403-409. PubMed ID: 32536056 [Abstract] [Full Text] [Related]
5. [The value of serum markers in evaluating liver fibrotic changes]. Hu YY, Liu P, Liu C, Liu CH, Xu LM. Zhonghua Gan Zang Bing Za Zhi; 2006 Mar 20; 14(3):174-7. PubMed ID: 16556409 [Abstract] [Full Text] [Related]
6. Fuzheng Huayu capsule as an adjuvant treatment for HBV-related cirrhosis: A systematic review and meta-analysis. Wang T, Zhou X, Liu H, Wang J, Zhang P, Zhu Y, Li K, Wei S, Li H, Wang L, Wang R, Zhao Y. Phytother Res; 2018 May 20; 32(5):757-768. PubMed ID: 29235181 [Abstract] [Full Text] [Related]
7. [Clinical observation on the safety and efficacy of ursodeoxycholic acid and fuzheng huayu capsule in the treatment of primary biliary cirrhosis]. Wu Y, Yao DK, Zhu L. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov 20; 32(11):1477-82. PubMed ID: 23359968 [Abstract] [Full Text] [Related]
8. [Efficacy Observation of Yiguanjian Decoction Combined Adefovir Dipivoxil Tablet in Treating HBeAg Negative Chronic Viral Hepatitis B Active Compensated Liver Cirrhosis Patients]. Duan SH, Bao ZY, Yuan XD, Wang L, Liu MS. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 May 20; 36(5):535-8. PubMed ID: 27386642 [Abstract] [Full Text] [Related]
9. [Effect of Fuzheng Huayu capsules on survival rate of patients with liver cirrhosis]. Ge XJ, Zhao CQ, Xu LM. Zhonghua Gan Zang Bing Za Zhi; 2017 Nov 20; 25(11):834-840. PubMed ID: 29325277 [Abstract] [Full Text] [Related]
10. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial]. Yin SS, Wang BE, Wang TL, Jia JD, Qian LX. Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 20; 12(8):467-70. PubMed ID: 15329205 [Abstract] [Full Text] [Related]
11. Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial. Chen Y, Zhao Z, Fan H, Li Z, He Y, Liu C. Contemp Clin Trials Commun; 2020 Sep 20; 19():100601. PubMed ID: 32642592 [Abstract] [Full Text] [Related]
12. Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosis. Cheng DY, Zhao ZM, Wan G, Zheng HW, Huang JQ, Liu CH, Xing HC. Hepatobiliary Pancreat Dis Int; 2022 Oct 20; 21(5):479-484. PubMed ID: 35346577 [Abstract] [Full Text] [Related]
13. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. Liu P, Hu YY, Liu C, Zhu DY, Xue HM, Xu ZQ, Xu LM, Liu CH, Gu HT, Zhang ZQ. World J Gastroenterol; 2002 Aug 20; 8(4):679-85. PubMed ID: 12174378 [Abstract] [Full Text] [Related]
14. [Effects of Fuzheng Huayu Capsule on the ratio of TGF-beta1/BMP-7 of chronic viral hepatitis B fibrosis patients of Gan-Shen insufficiency blood-stasis obstruction syndrome]. Tang CL, Zhou Z, Shi WQ. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan 20; 32(1):20-4. PubMed ID: 22500384 [Abstract] [Full Text] [Related]
15. Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells. Cheng Q, Li N, Chen M, Zheng J, Qian Z, Wang X, Huang C, Li Q, Lin Q, Shi G. J Ethnopharmacol; 2013 Jan 09; 145(1):175-81. PubMed ID: 23127651 [Abstract] [Full Text] [Related]
16. [Clinical research of xinganbao capsule on the treatment of chronic hepatitis B liver fibrosis]. Wang XB, Jiang YY, Zhao CY. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Mar 09; 32(3):325-8. PubMed ID: 22686076 [Abstract] [Full Text] [Related]
17. [A prospective cohort study on the influence of high doses of herbs for clearing heat and resolving stasis on survival rates in patients with hepatitis B-related acute-on-chronic liver failure]. Hu XY, Zhang Y, Chen G, Zhong S, Fan XJ. Zhong Xi Yi Jie He Xue Bao; 2012 Feb 09; 10(2):176-85. PubMed ID: 22313885 [Abstract] [Full Text] [Related]
18. [Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy]. Tian YL, Zhu XY, Yin WW, Zang ZD, Wang L, Fu XL. Zhonghua Gan Zang Bing Za Zhi; 2013 Jul 09; 21(7):514-8. PubMed ID: 24074710 [Abstract] [Full Text] [Related]
19. [Prevention and Therapeutic Effects of Fuzheng Huayu Capsule on Liver Fibrosis and Expression of Connective Tissue Growth Factor in Rats]. Chen H, Yang BW, Yuan M, Tang H, Bai L, Liu C, He M, Wang LC. Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Mar 09; 47(2):197-202. PubMed ID: 27263294 [Abstract] [Full Text] [Related]
20. [Multicentric randomized double blinded clinical study of Yiqi Tongmai Oral Liquid against angina pectoris in patients with coronary heart disease]. Zhang S, Song YQ, Yue W, Mao XR, Ju CX, Dong MJ, Zheng QL, Dai XH, Li ZY, Wang SP. Zhong Xi Yi Jie He Xue Bao; 2007 Jul 09; 5(4):383-91. PubMed ID: 17631800 [Abstract] [Full Text] [Related] Page: [Next] [New Search]